Scalper1 News
Shares of embattled specialty drugmaker Valeant Pharmaceuticals International (VRX) sank Monday as the company said its CEO would go on indefinite medical leave. Valeant sent an email to the press on Christmas Day stating that CEO J. Michael Pearson had been hospitalized for pneumonia, giving no further details. On Monday, the firm issued a formal press release saying that Pearson is on medical leave and that a three-man team composed of General Scalper1 News
Scalper1 News